Home » Topics » BioWorld Science

BioWorld Science
RSS

Chugai describes agents that stimulate gastrointestinal motility

Nov. 21, 1996

Kyorin claims cholinergic agents

Nov. 21, 1996

Pharmadigm (formerly Paradigm Biosciences) reports progress on lead therapeutic

Nov. 20, 1996

LTB4-PPARalpha as a new target for drug design

Nov. 20, 1996

First pivotal trial for panic disorder Rx

Nov. 20, 1996

Cephalon/Leo neurological disease collaboration

Nov. 20, 1996

Antimigraine drug from Vanguard to enter pivotal trials

Nov. 20, 1996

Recombinant NOVOMAb-G2 as potential cancer diagnostic

Nov. 20, 1996

HRT for preserving bone density in postmenopausal women

Nov. 20, 1996

Immunoregulating effect of IL-4 in IDDM

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...